Early data shows Novartis' experimental radiopharma drug reduces tumor markers in patients with advanced prostate cancer Novartis says 40% of cancer R&D investments going toward radiopharma therapies ...

When Congress passed what was then the Education for All Handicapped Children Act in 1975, it made a historic commitment: every child with a disability would receive a free appropriate public ...

Patients at the University of Chicago Medicine featured in a promotional video seamlessly refill prescriptions, book appointments and even get parking tips with the help of Agentforce, Salesforce Inc.

Adding Inhibrx Biosciences’ OX40 agonist to Keytruda doubled the response rate in a midphase clinical trial, encouraging the biotech to advance a program that reportedly attracted the interest of ...

Intravenous (IV) fosfomycin-based combination therapy was safe and well tolerated in high-risk paediatric patients (aged 0-18 years) with multidrug-resistant (MDR) infections, with minimal adverse ...

An investigational benzamide antipsychotic significantly improved symptoms in hospitalized adults with acute schizophrenia in a phase II trial. The drug, N-methyl amisulpride, is similar to its ...

Twenty years. That’s how long Native American families across Washington paid rent on homes they were promised they would one day own. After 20 years of monthly payments, maintaining their properties ...

CHARLOTTE, Tenn. (WSMV) - Along the back roads of Dickson County sits a community born out of strength, courage and determination. In the years after the Civil War, newly freed men and women from the ...

As the war with Iran rattles global energy markets and climate change drives the need for cleaner power, solar advocates are pointing to a fast-moving technology they believe could reshape the ...

Add Yahoo as a preferred source to see more of our stories on Google. It looks like President Donald Trump is going back on campaign promises – surprising no one familiar with his track record of ...

A prospective vaccine could offer future protection against Lyme disease. Pharmaceutical companies Pfizer and Valneva said their vaccine candidate was more than 70% effective at preventing Lyme ...